Home
News
Create
Screeners
Insights
Ambalal Sarabhai Enterprises
27.
78
+0.02
(+0.07%)
Market Cap
₹- Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.07%
1M
-13.97%
6M
-24.82%
1Y
-51.88%
5Y
+39.95%
View Company Insights
Latest news about Ambalal Sarabhai Enterprises
Ambalal Sarabhai Enterprises Reports Q2 Loss Despite Revenue Stability
Nov 13, 2025
Ambalal Sarabhai Enterprises Limited (ASE) reported mixed Q2 results with a 0.57% decrease in revenue to Rs 4,444.92 lakhs and a net loss of Rs 56.03 lakhs, down 121.39% year-over-year. The Electronics segment remained profitable with Rs 213.37 lakhs in segment results, while Pharmaceuticals reported a loss of Rs 121.14 lakhs. Half-year revenue reached Rs 8,478.80 lakhs with a net profit of Rs 766.32 lakhs. Total assets stood at Rs 26,019.34 lakhs with total equity of Rs 13,752.35 lakhs as of September 30.
Ambalal Sarabhai Enterprises' Joint Venture CoSara Diagnostics Explores SPAC Merger
Nov 06, 2025
Ambalal Sarabhai's Telerad Division Clinches Top Broadcast Award at Industry Show
Oct 27, 2025
Ambalal Sarabhai Enterprises Reports Stellar Q1 Performance with 2270% Profit Surge
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation